Paediatric DNA methylation profile scores: a systematic review and open-source atlas

Methylation profile scores (MPSs) have emerged as a useful tool to index exposures, biological states, or disease-related patterns, by aggregating information across many DNA methylation (DNAm) sites into a single score per individual. Although most MPSs to date have been trained and validated in adults, their use in early life (<18 years) is rapidly gaining momentum, as more cohorts profile DNAm during development, offering a window on exposures and vulnerability before disease onset. Here we systematically review early-life MPS studies (n = 119), covering 828 MPSs that span a wide range of exposures and traits. Overall, studies show substantial heterogeneity in design and reporting. Also, studies frequently apply MPSs trained in data from mismatched age groups, tissues, array or platforms, and ancestries, which may influence MPS performance. To address these limitations, we introduce DEMETRA (indepthlab-demetra.share.connect.posit.cloud), a searchable atlas of early-life MPSs to help users identify and select scores best suited to their study.

Authors

Institutions

Publication Details

Journal
EBioMedicine
Published
2026-05-22
DOI
https://doi.org/10.1016/j.ebiom.2026.106300
Primary Topic
Epigenetics and DNA Methylation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Paediatric DNA methylation profile scores: a systematic review and open-source atlas

Isabel K. Schuurmans, Serena Defina, Alexander Neumann, Janine F. Felix et al.
EBioMedicine
Epigenetics and DNA Methylation
article

Paediatric DNA methylation profile scores: a systematic review and open-source atlas

Isabel K. Schuurmans, Serena Defina, Alexander Neumann, Janine F. Felix, Charlotte A.M. Cecil, A.P.C. Hermans, Matthew Suderman, Paul Yousefi
article en

Abstract

Methylation profile scores (MPSs) have emerged as a useful tool to index exposures, biological states, or disease-related patterns, by aggregating information across many DNA methylation (DNAm) sites into a single score per individual. Although most MPSs to date have been trained and validated in adults, their use in early life (<18 years) is rapidly gaining momentum, as more cohorts profile DNAm during development, offering a window on exposures and vulnerability before disease onset. Here we systematically review early-life MPS studies (n = 119), covering 828 MPSs that span a wide range of exposures and traits. Overall, studies show substantial heterogeneity in design and reporting. Also, studies frequently apply MPSs trained in data from mismatched age groups, tissues, array or platforms, and ancestries, which may influence MPS performance. To address these limitations, we introduce DEMETRA (indepthlab-demetra.share.connect.posit.cloud), a searchable atlas of early-life MPSs to help users identify and select scores best suited to their study.

EBioMedicineVol. 128
University Hospitals Bristol NHS Foundation Trust (GB), Erasmus MC (NL), Erasmus University Rotterdam (NL)
National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology
Zero hunger
Openalex Percentile: Top 8%
Epigenetics and DNA Methylation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.